CAROLINE LEE: Open Payments
NPI 1447009808 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 34 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $209 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $192 |
| Procept Biorobotics Corporation | 2 | $109 |
| Sumitomo Pharma America, Inc. | 4 | $96 |
| Ferring Pharmaceuticals Inc. | 4 | $81 |
| ABBVIE INC. | 3 | $77 |
| Astellas Pharma US Inc | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Myriad Genetic Laboratories, Inc. | 2 | $42 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $30 |
Products named: Axonics, AQUABEAM ROBOTIC SYSTEM, ADSTILADRIN, BOTOX, GEMTESA, Xtandi, ORGOVYX, Nubeqa.
Industry payments across GA — which companies pay providers there.
